Press releases
- Press releases
- Browse
Press releases
Healthpoint Ltd. has announced that the United States Patent and Trademark Office has granted Healthpoint a Notice of Allowance on its patent application for the ointment vehicle that is the basis for Healthpoint's Xenaderm(tm). More
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx® GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers More
Turkish patent office issues first Topical Nimesulide Patent for SULIDIN® under the title 'Nimesulide containing topical formulations'. More
Rapid In-vitro Percutaneous Penetration Profile of Sulidin® 1% Nimesulide LPS topical gel to be presented at the 8'th International Conference on Percutaneous Penetration. More
Foamix is partnering with leading phamaceutical companies in developing their drugs in foam formulations. The company will present at the upcoming American Academy of Dermatology meeting in New Orleans on February 18-22, 2005 More
Ness Ziona ISRAEL, April 7, 2005 - Foamix Ltd., a leader in developing innovative topical delivery systems, enters new state-of-the-art facility. More
Dr Duncan Aust joins one of the fastest growing R & D groups in the industry: Dedicated to dermatology, skin diseases and wound and tissue management. More
HEALTHPOINT will strive for an uninterrupted supply of IODOSORB(R) Gel and IODOFLEX(R) Pad absorbent antimicrobials to their customers as the licensing agreement with Smith & Nephew for these products expires. More
The Population Council, an international public health organisation and FemPharm Pty Ltd., a wholly-owned subsidiary of Acrux Limited, have signed a joint development agreement to test transdermal spray delivery of contraceptive formulations of Nesto More
Acrux appoints Ms Carla Gervasio Nugent as the Chief Executive Officer of its investee company Cosmeceutic Solutions. The company was set up earlier this year to develop novel skin care products for the global cosmetic markets. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 124 pages - $1,740
Apr 2007 - 118 pages - $2,495
Feb 2006 - 332 pages - $3,900
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Jun 2009 - 110 pages - $1,040
Jan 2008 - 330 pages - $4,200
Jan 2010 - 250 pages - $3,900
Dec 2006 - 90 pages - $995
Jun 2009 - 472 pages - $3,140
Your selection
Browse By
- Industry sector
- Aerosol
- Collodion/Lacquer
- Dressing
- Emulsion
- Foam
- Gel
- Liquid
- Ointment
- Other
- Spray
- Suspension
- Wash/Soap
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us